Scott Daniel Cormack insider trades: Oncogenex Pharmaceuticals (OGXI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2016 | OGXI | ↓ Sell | 4,856 | $1.03 | $5K | Direct | Jun 15, 2016 (2d) |
| Mar 15, 2016 | OGXI | ↓ Sell | 12,033 | $0.83 | $10K | Direct | Mar 16, 2016 (1d) |
| Jun 12, 2015 | OGXI | ↓ Sell | 4,571 | $2.69 | $12K | Direct | Jun 16, 2015 (4d) |
| May 20, 2015 | OGXI | ↓ Sell | 7,543 | $1.88 | $14K | Direct | May 21, 2015 (1d) |
| Aug 13, 2014 | OGXI | ↓ Sell | 18,341 | $3.17 | $58K | Direct | Aug 14, 2014 (1d) |
| Mar 17, 2014 | OGXI | ↓ Sell | 4,634 | $12.25 | $57K | Direct | Mar 18, 2014 (1d) |
| Jan 4, 2011 | OGXI | ↓ Sell | 6,608 | $16.52 | $109K | Direct | Jan 6, 2011 (2d) |
| Jan 4, 2011 | OGXI | ↓ Sell | 3,392 | $16.52 | $56K | Spouse | Jan 6, 2011 (2d) |
| Dec 1, 2010 | OGXI | ↓ Sell | 5,000 | $16.02 | $80K | Direct | Dec 3, 2010 (2d) |
| Nov 15, 2010 | OGXI | ↓ Sell | 5,000 | $15.99 | $80K | Spouse | Nov 17, 2010 (2d) |
| Nov 1, 2010 | OGXI | ↓ Sell | 5,000 | $15.45 | $77K | Direct | Nov 2, 2010 (1d) |
| Sep 26, 2008 | OGXI | ↑ Buy | 5,000 | $3.99 | $20K | Direct | Sep 29, 2008 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Scott Daniel Cormack's insider trades
Scott Daniel Cormack is President and CEO at Oncogenex Pharmaceuticals (OGXI). Since Sep 26, 2008, Scott has reported 1 open-market purchase worth $20K and 11 sales worth $559K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (25 filings), grants and awards (14 filings), shares withheld for taxes (7 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OGXI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.